The RTS,S vaccine—a chance to regain the upper hand against malaria?

Photini Sinnis; David A. Fidock

doi:10.1016/j.cell.2022.01.028

The RTS,S vaccine—a chance to regain the upper hand against malaria?

Photini Sinnis, David A. Fidock

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Malaria is estimated by the World Health Organization (WHO) to have killed 627,000 individuals worldwide in 2020, with nearly 80% of deaths in African children younger than five. The recent WHO approval of the RTS,S/AS01 vaccine, which targets Plasmodium falciparum pre-erythrocytic stages, provides hope that its use combined with other interventions can help reverse the current malaria resurgence.

Original language	English (US)
Pages (from-to)	750-754
Number of pages	5
Journal	Cell
Volume	185
Issue number	5
DOIs	https://doi.org/10.1016/j.cell.2022.01.028
State	Published - Mar 3 2022

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/j.cell.2022.01.028

Cite this

@article{133906e17f42402ab7bd04dc50f7252d,

title = "The RTS,S vaccine—a chance to regain the upper hand against malaria?",

abstract = "Malaria is estimated by the World Health Organization (WHO) to have killed 627,000 individuals worldwide in 2020, with nearly 80% of deaths in African children younger than five. The recent WHO approval of the RTS,S/AS01 vaccine, which targets Plasmodium falciparum pre-erythrocytic stages, provides hope that its use combined with other interventions can help reverse the current malaria resurgence.",

author = "Photini Sinnis and Fidock, {David A.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = mar,

day = "3",

doi = "10.1016/j.cell.2022.01.028",

language = "English (US)",

volume = "185",

pages = "750--754",

journal = "Cell",

issn = "0092-8674",